EVEREST - IBD

  • Research type

    Research Study

  • Full title

    EVEREST-IBD: Endoscopic severity image recognition to advance research and training in Inflammatory Bowel Disease

  • IRAS ID

    299614

  • Contact name

    Shaji Sebastian

  • Contact email

    shaji.sebastian@hey.nhs.uk

  • Sponsor organisation

    Hull University Teaching Hospitals NHS Trust

  • Duration of Study in the UK

    3 years, 0 months, 30 days

  • Research summary

    Crohn's Disease (CD) and Ulcerative Colitis (UC) are chronic inflammatory bowel diseases (IBD) of unknown aetiology. IBD care is complex, and variation in diagnostic pathways, care patterns and outcomes is common, numerous studies show significant variation in IBD management across all clinical care settings. Endoscopy is a cornerstone of IBD management. Endoscopy is utilized to identify inflammation including its pattern, location and to differentiate inflammation from non-inflammatory pathology, such as dysplasia. Endoscopic assessment also plays an integral part in disease exacerbation management and cancer surveillance.
    Endoscopic scoring systems in IBD provide objectively, uniformity and standardization with reporting of mucosal appearances, augmenting clinical decision making and ultimately having an impact on appropriate treatment targets and desirable patient outcomes. Real-world endoscopic reporting is, however, limited by inconsistent use of standardized scoring systems, imprecision, and variation in reporting, through significant interpretative element.
    Currently endoscopic practice depends on the ability of the operator to detect and interpret abnormal images produced from light reflected off gastrointestinal tract mucosal surfaces. Endoscopic assessments are naturally operator-dependent with high inter-observer variability. The study will collect a large number of endoscopic images both prospectively and retrospectively to produce high impact research outcomes and training resources leading to an improvement in the quality of endoscopy performed, reduce inter-observer variability in disease assessment and a reduction in missed bowel cancer rates and associated mortality.

  • REC name

    Yorkshire & The Humber - Leeds East Research Ethics Committee

  • REC reference

    21/YH/0110

  • Date of REC Opinion

    10 Jul 2021

  • REC opinion

    Further Information Favourable Opinion